MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Intersect ENT Company Profile (NASDAQ:XENT)

Consensus Ratings for Intersect ENT (NASDAQ:XENT) (?)
Ratings Breakdown: 9 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $27.67 (36.02% upside)

Analysts' Ratings History for Intersect ENT (NASDAQ:XENT)
Show:
DateFirmActionRatingPrice TargetActions
3/29/2016Northland SecuritiesInitiated CoverageOutperform$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2016Cantor FitzgeraldReiterated RatingBuy$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016WedbushReiterated RatingOutperform$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015Bank of AmericaInitiated CoverageBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2015Piper JaffrayReiterated RatingBuy$30.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2015Sterne Agee CRTReiterated RatingBuy$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2015JPMorgan Chase & Co.Boost Price TargetOverweight$28.00 -> $37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2015CRT CapitalInitiated CoverageBuy$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/11/2014William BlairInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/6/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha